A potential non‐invasive glioblastoma treatment: Nose‐to‐brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Controlled Release

• Publication date

  2017-09-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jconrel.2017.06.032PMID 28684169
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Farnesylthiosalicylic acid‐loaded lipid–polyethylene glycol–polymer hybrid nanoparticles for treatment of glioblastoma

  2017cited by this paper
• A prodrug micellar carrier assembled from polymers with pendant farnesyl thiosalicylic acid moieties for improved delivery of paclitaxel.

  2016cited by this paper
• Nose to Brain Delivery of Midazolam Loaded PLGA Nanoparticles: In Vitro and In Vivo Investigations.

  2016cited by this paper
• Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration.

  2015cited by this paper
• Phase I study of S-trans, trans-farnesylthiosalicylic acid (salirasib), a novel oral RAS inhibitor in patients with refractory hematologic malignancies.

  2015cited by this paper
• 128OPhase I study of S-trans, trans-farnesylthiosalicylic acid (salirasib), a novel oral RAS inhibitor in Japanese patients with advanced solid tumors

  2015cited by this paper
• Targeted Delivery of Curcumin to Tumors via PEG-Derivatized FTS-Based Micellar System

  2014cited by this paper
• PEG-Farnesyl Thiosalicylic Acid Telodendrimer Micelles as an Improved Formulation for Targeted Delivery of Paclitaxel

  2014cited by this paper
• Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

  2013cited by this paper
• Analgesic potential of intrathecal farnesyl thiosalicylic acid and GW 5074 in vincristine-induced neuropathic pain in rats.

  2012cited by this paper
• Ras inhibition by FTS attenuates brain tumor growth in mice directly and by enhancing reactivity of cytotoxic lymphocytes

  2012cited by this paper
• Ras inhibition by FTS attenuates brain tumor growth in mice directly and by enhancing reactivity of cytotoxic lymphocytes

  2012cited by this paper
• Nanostructure-based drug delivery systems for brain targeting

  2012cited by this paper
• Could nanoparticle systems have a role in the treatment of cerebral gliomas?

  2011cited by this paper
• Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain.

  2011cited by this paper
• Cationic ligand appended nanoconstructs: a prospective strategy for brain targeting.

  2011cited by this paper
• Nanotechnology advances in brain tumors: the state of the art.

  2011cited by this paper
• Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles.

  2011cited by this paper
• Current State of Our Knowledge on Brain Tumor Epidemiology

  2011cited by this paper
• Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models.

  2010cited by this paper
• Micellar Nanocarriers: Potential Nose-to-Brain Delivery of Zolmitriptan as Novel Migraine Therapy

  2010cited by this paper
• Imaging of brain tumors: perfusion/permeability.

  2010cited by this paper
• Targeted imaging and therapy of brain cancer using theranostic nanoparticles.

  2010cited by this paper
• Quick synthesis of lipid-polymer hybrid nanoparticles with low polydispersity using a single-step sonication method.

  2010cited by this paper
• Phase 1 first-in-human clinical study of S-trans, trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors

  2009cited by this paper
• Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking.

  2009cited by this paper
• New derivatives of farnesylthiosalicylic acid (salirasib) for cancer treatment: farnesylthiosalicylamide inhibits tumor growth in nude mice models.

  2009cited by this paper
• Salirasib (farnesyl thiosalicylic acid) for brain tumor treatment: a convection-enhanced drug delivery study in rats

  2008cited by this paper
• Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier.

  2008cited by this paper
• Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.

  2008cited by this paper
• Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles

  2008cited by this paper
• Determination of salirasib (S-trans,trans-farnesylthiosalicylic acid) in human plasma using liquid chromatography-tandem mass spectrometry.

  2008cited by this paper
• Abstract 1561: Ras/Raf/p38 MAPK/ERK Pathway is Activated in the Rostral Ventrolateral Medulla of Stroke-Prone Spontaneously Hypertensive Rats

  2008cited by this paper
• Phase I Study of S-trans, Trans-farnesylthiosalicylic Acid (FTS), a Novel Oral Ras Inhibitor, in Patients with Refractory Hematologic Malignancies.

  2007cited by this paper
• Suppression of lung cancer tumor growth in a nude mouse model by the Ras inhibitor salirasib (farnesylthiosalicylic acid)

  2007cited by this paper
• The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats

  2006cited by this paper
• A Ras inhibitor tilts the balance between Rac and Rho and blocks phosphatidylinositol 3-kinase-dependent glioblastoma cell migration.

  2006cited by this paper
• TREATMENT OF MALIGNANT GLIOMAS WITH MITOXANTRONE‐LOADED POLY (LACTIDE‐CO‐GLYCOLIDE) MICROSPHERES

  2006cited by this paper
• Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosis

  2006cited by this paper
• Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.

  2006cited by this paper
• The Ras Inhibitor Farnesylthiosalicylic Acid as a Potential Therapy for Neurofibromatosis Type 1

  2006cited by this paper
• Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death.

  2005cited by this paper
• Comparison of the effects of perfusion in determining brain penetration (brain-to-plasma ratios) of small molecules in rats.

  2004cited by this paper
• Modeling of cationic lipid-DNA complexes.

  2004cited by this paper
• Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid.

  2004cited by this paper
• Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles for Intracellular Delivery

  2003cited by this paper
• Drug Transport into the Mammalian Brain: The Nasal Pathway and its Specific Metabolic Barrier

  2002cited by this paper
• Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor Targeting

  2002cited by this paper
• Long-Circulating Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles for Intracellular Delivery

  2002cited by this paper
• Long-circulating and target-specific nanoparticles: theory to practice.

  2001cited by this paper
• “Jackson”

  2001cited by this paper
• Biodegradable poly(D,L-lactic acid)-poly(ethylene glycol)-monomethyl ether diblock copolymers: structures and surface properties relevant to their use as biomaterials.

  2000cited by this paper
• Transport of drugs from the nasal cavity to the central nervous system.

  2000cited by this paper
• Polymer-coated long-circulating microparticulate pharmaceuticals.

  1998cited by this paper
• Quantitative analysis of the olfactory pathway for drug delivery to the brain.

  1995cited by this paper
• Spread of MHV-JHM from nasal cavity to white matter of spinal cord. Transneuronal movement and involvement of astrocytes.

  1995cited by this paper
• Accumulation of Cd(II) in the CNS depending on the route of administration: intraperitoneal, intratracheal, or intranasal.

  1992cited by this paper
• Radiation and drug response of the rat glioma RG2.

  1982cited by this paper
• Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

  1980cited by this paper

• Intranasal hybrid nanoparticles encapsulating rizatriptan enhance antimigraine efficacy in an optogenetic spreading depression model.

  2026cites this paper
• Exploring manganese-loaded nanoparticle formulations as contrast agents: A comprehensive in vitro and in vivo study.

  2026cites this paper
• CAMK2B Impacts the Proliferation, Invasion, and Migration of Glioma Cells via the Ras/Raf/MEK/ERK Signaling Pathway

  2025cites this paper
• Polymeric nanoparticles for efficient nose-to-brain delivery.

  2025cites this paper
• Breaking the Brain Barrier: Hybrid Nanoparticle-Enabled Delivery for Next-Gen Neurotherapeutics

  2025cites this paper
• Unlocking the potential of lipid nanoparticles for enhanced glioma therapy: Recent advancements and future perspectives.

  2025cites this paper
• Nose-to-brain delivery of sorafenib-loaded lipid-based poloxamer-carrageenan nanoemulgel: Formulation and therapeutic investigation in glioblastoma-induced orthotopic rat model.

  2025cites this paper
• Insights into Targeted and Stimulus‐Responsive Nanocarriers for Brain Cancer Treatment

  2024cites this paper
• Exploring intranasal drug delivery via nanocarriers: A promising glioblastoma therapy.

  2024cites this paper
• Current strategic arsenal and advances in nose to brain nanotheranostics for therapeutic intervention of glioblastoma multiforme

  2024cites this paper
• To see or not to see: In vivo nanocarrier detection methods in the brain and their challenges.

  2024cites this paper
• Therapeutic and Toxicological Aspects of Some Metal Nanoparticles on The Central Nervous System: A Review

  2024cites this paper
• A comprehensive review on lipid nanocarrier systems for cancer treatment: fabrication, future prospects and clinical trials

  2023cites this paper
• Nose-to-brain drug delivery for the treatment of glioblastoma multiforme: nanotechnological interventions

  2023cites this paper
• Recent progress in the intranasal PLGA-based drug delivery for neurodegenerative diseases treatment

  2023influential citation
• Polysaccharide-based platforms for nasal delivery: design, features, and perspectives

  2023cites this paper
• Lipid-Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities

  2023cites this paper
• Development and characterization of polymeric nanoparticles containing ondansetron hydrochloride as a hydrophilic drug

  2022cites this paper
• Lipid polymer hybrid nanocarriers: Insights into synthesis aspects, characterization, release mechanisms, surface functionalization and potential implications

  2022cites this paper
• Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo.

  2022cites this paper
• Intranasal Delivery of Functionalized Polymeric Nanomaterials to the Brain

  2022cites this paper
• Untangling Mucosal Drug Delivery: Engineering, Designing, and Testing Nanoparticles to Overcome the Mucus Barrier.

  2022cites this paper
• Restoration of olfactory dysfunctions by nanomaterials and stem cells-based therapies: Current status and future perspectives

  2022cites this paper
• Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases

  2022cites this paper
• A Comprehensive Review on Nanomedicine: Promising approach for treatment of brain tumor through intranasal administration.

  2022cites this paper
• A simple self-assembly nanomicelle based on brain tumor-targeting peptide-mediated siRNA delivery for glioma immunotherapy via intranasal administration.

  2022cites this paper
• Physiology of nose-to-brain pathways and current approaches to intranasal treatment

  2022cites this paper
• An overview of nanotechnological applications in biomedical engineering

  2022cites this paper
• Intranasal delivery of phenytoin-loaded nanoparticles to the brain suppresses pentylenetetrazol-induced generalized tonic clonic seizures in an epilepsy mouse model.

  2021cites this paper
• Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches

  2021cites this paper
• Direct nose to the brain nanomedicine delivery presents a formidable challenge.

  2021cites this paper
• Functionalized Nanomaterials as Tailored Theranostic Agents in Brain Imaging

  2021cites this paper
• Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches

  2021cites this paper
• Blood–brain-barrier crossing nanotheranostics in brain cancer

  2021cites this paper
• Nanopolymeric systems to improve brain cancer treatment outcomes

  2021cites this paper
• NOSE-TO-BRAIN DELIVERY, A ROUTE OF CHOICE FOR TARGETING BRAIN TUMORS

  2021cites this paper
• Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier

  2021cites this paper
• Mucoadhesion as a strategy to enhance the direct nose-to-brain drug delivery

  2021cites this paper
• Nanotechnological advances in direct nose-to-brain drug delivery for neurodegenerative disorders and other neuroailments

  2021cites this paper
• Gather wisdom to overcome barriers: Well-designed nano-drug delivery systems for treating gliomas

  2021cites this paper
• Nose-to-brain delivery of teriflunomide-loaded lipid-based carbopol-gellan gum nanogel for glioma: Pharmacological and in vitro cytotoxicity studies.

  2020cites this paper
• Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration.

  2020cites this paper
• Nanomedicine Revisited: Next Generation Therapies for Brain Cancer

  2020cites this paper
• Mixed Self-Assembled Amphiphilic Polymeric Nanoparticles for Intranasal Drug Delivery

  2020cites this paper
• Nose-to-brain delivery of antiglioblastoma drugs embedded into lipid nanocarrier systems: status quo and outlook.

  2020cites this paper
• Characterization of focused ultrasound-mediated brainstem delivery of intranasally administered agents.

  2020cites this paper
• Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art

  2020cites this paper
• Current Developments in Targeted Drug Delivery Systems for Glioma.

  2020cites this paper
• Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management

  2020cites this paper
• Mixed Amphiphilic Polymeric Nanoparticles of Chitosan, Poly(vinyl alcohol) and Poly(methyl methacrylate) for Intranasal Drug Delivery: A Preliminary In Vivo Study

  2020cites this paper
• Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials

  2019influential citation
• 1 Nasal Drug Delivery of Anticancer Drugs for the 2 Treatment of Glioblastoma : Preclinical and Clinical 3 Trials 4

  2019cites this paper
• Radiation-Induced Targeted Nanoparticle-Based Gene Delivery for Brain Tumor Therapy.

  2019cites this paper
• Assessment of the toxicity of lipid nanocapsules and polymer nanoparticles on a neuronal cell model as a first step towards their development for nose-to-brain drug delivery

  2019cites this paper
• Thirty Years of Cancer Nanomedicine: Success, Frustration, and Hope

  2019cites this paper
• Impact of Nanoparticles on Brain Health: An Up to Date Overview

  2018cites this paper
• Recent advances in carrier mediated nose‐to‐brain delivery of pharmaceutics

  2018cites this paper
• 1 Surface-modified nanocarriers for nose-to-brain 2 delivery : from bioadhesion to targeting 3

  2018cites this paper
• DEVELOPMENT, EVALUATION AND TARGETING OF IMATINIB MESYLATE LOADED SOLID LIPID NANOPARTICLES TO THE LYMPHATIC SYSTEM

  2018cites this paper
• Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting

  2018cites this paper
• Enhanced blood–brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles

  2018cites this paper